Hemostatics Concept

subject area of

• A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME)  Academic Article
• A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose  Academic Article
• A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins  Academic Article
• A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery  Academic Article
• APPLICATION OF NOVEL HEMOSTATIC AGENT DURING LAPAROSCOPIC PARTIAL NEPHRECTOMY  Academic Article
• Acute management of bleeding in patients on novel oral anticoagulants  Academic Article
• Acute reversal of anticoagulant-induced bleeding complications.  Academic Article
• Bleeding and antidotes in new oral anticoagulants  Academic Article
• Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency  Academic Article
• Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study  Academic Article
• Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII  Academic Article
• Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor  Academic Article
• Feasibility of using recombinant factor VIIa in continuous infusion.  Academic Article
• Fibrin Sealant in Surgery of Patients with a Hemorrhagic Diathesis  Conference Paper
• Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding  Academic Article
• Haemostatic and replacement therapy in von Willebrand disease  Academic Article
• Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study  Academic Article
• How I treat target-specific oral anticoagulant–associated bleeding  Academic Article
• Immune Responses Associated With Perioperative Exposure and Reexposure to Topical Bovine Thrombin Do Not Impair Hemostasis  Academic Article
• Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin  Academic Article
• Management of Inheritedvon Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients  Academic Article
• Management of bleeding with oral anticoagulants in patients with atrial fibrillation  Academic Article
• Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents  Conference Paper
• Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding  Academic Article
• NXY-059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Phase I Study  Academic Article
• New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management  Conference Paper
• New method for packing the external auditory canal, middle ear space, and mastoid cavities after otologic surgery  Academic Article
• Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report)  Academic Article
• Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH  Academic Article
• Plasma-derived biological medicines used to promote haemostasis  Academic Article
• Platelet substitutes.  Academic Article
• Pre-Procedure Desmopressin Acetate to Reduce Bleeding in Renal Failure: Does It Really Work?  Academic Article
• Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trials.  Academic Article
• Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study  Academic Article
• Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis  Academic Article
• Randomized study of aprotinin effect on transfusions and blood loss in primary THA.  Academic Article
• Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse  Academic Article
• Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent  Academic Article
• Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1  Academic Article
• Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates  Academic Article
• Thromboelastometry reveals similar hemostatic properties of purified fibrinogen and a mixture of purified cryoprecipitate protein components  Academic Article
• Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis  Academic Article
• Understanding FVIII/VWF complex - report from a symposium of XXIX WFH meeting 2010  Academic Article
• Undetected factor VIII in a patient with type 3 von Willebrands disease mistaken as severe haemophilia A  Academic Article
• [New preparations for coagulation disorders].  Academic Article